Yale Jen
Stock Analyst at Laidlaw & Co.
(0.07)
# 4,489
Out of 5,169 analysts
15
Total ratings
7.14%
Success rate
-18.41%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $23.23 | +158.29% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.58 | +1,020.69% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $2.79 | +688.53% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $0.98 | +410.20% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $33.62 | +212.31% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.71 | +118.14% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $7.56 | +1,487.30% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $126.62 | -62.09% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $5.23 | +8,982.22% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.94 | +11,497.94% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.66 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.33 | +2,976.92% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.12 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $23.23
Upside: +158.29%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.58
Upside: +1,020.69%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $2.79
Upside: +688.53%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $0.98
Upside: +410.20%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $33.62
Upside: +212.31%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.71
Upside: +118.14%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $7.56
Upside: +1,487.30%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $126.62
Upside: -62.09%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $5.23
Upside: +8,982.22%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.94
Upside: +11,497.94%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.66
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.33
Upside: +2,976.92%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.12
Upside: -